(Q43235417)

16 November 2017

title

Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania (English)

1 reference

16 November 2017

0 references

0 references

5

1 reference

16 November 2017

7

1 reference

16 November 2017

13

1 reference

16 November 2017

Guilherme Alves Elias

Guilherme Elias

2

0 references

Antonio Waldo Zuardi

12

Antonio W Zuardi

1 reference

16 November 2017

6

Flávio Kapczinski

1 reference

Jaime Eduardo Cecilio Hallak

16 November 2017

11

Jaime E C Hallak

1 reference

José Alexandre de Souza Crippa

16 November 2017

14

José A S Crippa

1 reference

16 November 2017

Samira S Valvassori

1

1 reference

16 November 2017

Bruna de Souza

3

1 reference

16 November 2017

Fabrícia Petronilho

4

1 reference

16 November 2017

Vitor Tumas

8

1 reference

16 November 2017

Serdar Dursun

9

1 reference

16 November 2017

Marcos Hortes Nisihara Chagas

10

1 reference

16 November 2017

language of work or name

English

0 references

publication date

25 November 2009

1 reference

Journal of Psychopharmacology

16 November 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

16 November 2017

volume

25

1 reference

16 November 2017

issue

2

1 reference

16 November 2017

page(s)

274-280

1 reference

Oxidative stress markers in bipolar disorder: a meta-analysis

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

GABA-ergic drugs: exit stage left, enter stage right

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Imaging the neural effects of cannabinoids: current status and future opportunities for psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Letter: Cannabidiol and Cannabis sativa extract protect mice and rats against convulsive agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Schizandrin protects primary cultures of rat cortical cells from glutamate-induced excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Effects of cannabidiol (CBD) on regional cerebral blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Antianxiety effect of cannabidiol in the elevated plus-maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Comparison of cannabidiol, antioxidants, and diuretics in reversing binge ethanol-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Fluvastatin prevents glutamate-induced blood-brain-barrier disruption in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Emerging drugs for bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Hypnoticlike effects of cannabidiol in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

History of cannabis as a medicine: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Cannabidiol for the treatment of psychosis in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Cannabidiol monotherapy for treatment-resistant schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106925

21 January 2018

Identifiers

DOI

10.1177/0269881109106925

1 reference

16 November 2017

1 reference